McClain v. Sav-On Drugs

435 P.3d 424, 244 Cal. Rptr. 3d 138, 6 Cal. 5th 951
CourtCalifornia Supreme Court
DecidedMarch 4, 2019
DocketS241471
StatusPublished
Cited by14 cases

This text of 435 P.3d 424 (McClain v. Sav-On Drugs) is published on Counsel Stack Legal Research, covering California Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McClain v. Sav-On Drugs, 435 P.3d 424, 244 Cal. Rptr. 3d 138, 6 Cal. 5th 951 (Cal. 2019).

Opinion

Opinion of the Court by Liu, J.

**426 *140 *954 California retailers are generally required to pay the state a sales tax on the retail sale of any "tangible personal property." ( Rev. & Tax. Code, § 6051.) Retailers submit payment to the California Department of Tax and Fee Administration (CDTFA or Department) as a percentage of their gross receipts under a rebuttable presumption that all gross receipts are subject to the sales tax. ( Id. , §§ 6051, 6091.) Retailers may charge customers a "sales tax reimbursement to the sales price" for sales subject to the tax, or they may absorb the tax and opt to build it into the price charged to consumers. ( Civ. Code, § 1656.1 ; see Loeffler v. Target Corp. (2014) 58 Cal.4th 1081 , 1103, 1117, 171 Cal.Rptr.3d 189 , 324 P.3d 50 ( Loeffler ).)

If a retailer believes it has paid sales tax in excess of the amount legally due, it can file an administrative claim with the Department for a refund of any amount not required to be paid. ( Rev. & Tax. Code, § 6901.) If it "has been ascertained" that a customer has paid a retailer more sales tax reimbursement than the amount of sales tax the retailer owes, the retailer upon *955 notice by the Department or the customer "shall ... return[ ]" the excess sales tax reimbursement to the customer; if the retailer "fail[s] or refuse[s] to do so," the retailer "shall ... remit[ ]" the funds to the state. ( Id. , § 6901.5.) A customer who has paid excess sales tax reimbursement has no statutory remedy *141 to obtain a refund from the Department directly. (See Javor v. State Bd. of Equalization (1974) 12 Cal.3d 790 , 800, 117 Cal.Rptr. 305 , 527 P.2d 1153 ( Javor ).) (The Legislature created the CDTFA in 2017 and transferred to it most of the tax-related duties and powers previously vested in the Board of Equalization (Board). (Assem. Bill. No. 102 (2017-2018 Reg. Sess.) § 1.) In this opinion, the terms "Department" and "Board" refer to the same administrative entity.)

The question here is whether customers who have paid sales tax reimbursement on purchases they believe to be exempt from sales tax may file suit to compel the retailers to seek a tax refund from the Department when there has been no determination by the Department or a court that the purchases are exempt. In Javor , we authorized a customer suit where the Board, upon determining that certain retailers had collected excess sales tax reimbursement, had promulgated rules to provide refunds to overpaying customers. The trial court declined to extend Javor to authorize a similar judicial remedy in this case, and the Court of Appeal affirmed. ( McClain v. Sav-On Drugs (2017) 9 Cal.App.5th 684 , 700-702, 215 Cal.Rptr.3d 416 ( McClain ).) We agree with the courts below in refusing to extend Javor and affirm the judgment sustaining defendants' demurrer.

I.

Section 6369, subdivision (e) of the Revenue and Taxation Code exempts "[i]nsulin and insulin syringes" from sales tax if "furnished by a registered pharmacist to a person for treatment of diabetes as directed by a **427 physician." (All undesignated statutory references are to the Revenue and Taxation Code.) In 2000, the Board issued a regulation interpreting the exemption in section 6369, subdivision (e) to cover "[g]lucose test strips and skin puncture lancets furnished by a registered pharmacist" for use by a diabetic patient "in accordance with a physician's instructions." ( Cal. Code Regs., tit. 18, § 1591.1, subd. (b)(5) (hereafter regulation 1591.1(b)(5)); see § 7051 ["The board ... may prescribe, adopt, and enforce rules and regulations relating to the administration and enforcement" of the sales tax].) The Board's Final Statement of Reasons explained that the test strips and lancets are "so integrated with the operation of insulin and insulin syringes (the syringes cannot be used until the patient has first tested his blood sugar using the lancets and test strips) that the Legislature intended that their sales be exempt from tax as part and parcel of the exemption for sales of insulin syringes under section 6369(e)." (State Bd. of Equalization, Final *956 Statement of Reasons/Plain English: Regulations 1591, 1591.1, 1591.2, 1591.3 & 1591.4 (Dec. 28, 1999) p. 4.)

In 2003, in response to "inconsistencies" in how regulation 1591.1(b)(5) was being applied, the Board's Program Planning Manager sent a letter to California retail pharmacies setting forth the conditions for when the sale of a test strip or lancet is exempt from tax. (State Bd. of Equalization Program Planning Manager Charlotte Paliani, letter to Albertson's re regulation 1591.1, June 18, 2003 (hereafter Paliani Letter).) The letter explained that the retailer must be provided with a copy of the patient's physician instructions, that the retailer must maintain a copy of the instructions in its records, and that the lancet or test strip must be kept in a secure location and dispensed by a registered pharmacist. Only then, according to the letter, is the sale exempt from tax. (Paliani Letter, supra ["However, if your customers are able to remove the items directly off the shelf and pay for them at your store's registers, without a pharmacist's *142 intervention, the sales are subject to tax."].)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
435 P.3d 424, 244 Cal. Rptr. 3d 138, 6 Cal. 5th 951, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcclain-v-sav-on-drugs-cal-2019.